IMU.AX - Imugene Limited
NEXT EARNINGS:
Mar 4, 2026
(in 7 days)
EPS Est: $-0.34
|
Rev Est: $2.0M
Price:
--
--
Market Cap:
81.99M
Volume:
1,240,195
Avg Volume:
1,355,267
52 Week Range:
0.24-1.394
Sector:
Healthcare
Industry:
Biotechnology
Beta:
2.59
Last Dividend:
$N/A
Exchange:
ASX
Country:
AU
Employees:
0
IPO Date:
1998-12-31
EPS (TTM):
-0.32
P/E Ratio:
-1.40
Revenue (TTM):
4.40M
Total Assets:
83.59M
Total Debt:
10.65M
Cash & Equiv:
21.94M
Rev Growth (5Y):
1.2%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-114.0%
Debt/Equity:
0.24
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-02-27 | $-0.01 | $-0.01 | +34.7% | $1.3M | $7.0M | -82.0% |
| 2024-10-31 | $-0.01 | $-0.01 | -11.0% | $-1550000 | — | — |
| 2024-04-30 | $-0.01 | — | — | $8.1M | — | — |
| 2023-10-31 | $-0.00 | — | — | $7.0M | — | — |
| 2023-03-01 | $-0.00 | — | — | $4.8M | — | — |
| 2022-06-30 | $-0.00 | — | — | $7.6M | — | — |
| 2021-12-31 | $-0.00 | $-0.00 | -173.0% | $5.3M | — | — |
| 2021-06-30 | $-0.00 | $-0.00 | -66.7% | $3.1M | — | — |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4.40M | 4.97M | 11.78M | 12.97M | 7.23M | 4.13M | 4.13M | 1.84M | 1.16M | 1.56M | 638,676 | 538,312 |
| Net Income | (69.02M) | (149.68M) | (37.91M) | (37.87M) | (18.45M) | (10.51M) | (7.78M) | (3.93M) | (2.51M) | (2.73M) | (2.44M) | (2.12M) |
| EPS | -0.32 | -0.72 | -0.21 | -0.23 | -0.13 | -0.09 | -0.07 | -0.05 | -0.04 | -0.07 | -0.07 | -0.10 |
| Total Assets | 83.59M | 151.40M | 197.06M | 147.61M | 71.81M | 65.20M | 30.78M | 16.91M | 12.68M | 9.54M | 9.11M | 8.63M |
| Total Debt | 10.65M | 2.19M | 553,472 | 673,432 | 271,029 | 69,336 | 122,896 | 0 | 0 | 0 | 0 | 0 |
| Cash & Equivalents | 21.94M | 93.11M | 153.15M | 99.89M | 29.49M | 30.11M | 19.05M | 7.82M | 4.81M | 1.58M | 1.96M | 1.22M |
| Operating Cash Flow | (75.57M) | (101.73M) | (29.78M) | (30.67M) | (13.13M) | (10.13M) | (7.91M) | (4.51M) | (2.67M) | (3.05M) | (2.04M) | (1.14M) |
| Free Cash Flow | (90.03M) | (108.80M) | (29.78M) | (30.93M) | (18.58M) | (11.62M) | (8.04M) | (4.51M) | (2.68M) | (3.05M) | (2.51M) | (1.74M) |
| FCF per Share | -0.41 | -0.52 | -0.16 | -0.19 | -0.14 | -0.10 | -0.08 | -0.06 | -0.04 | -0.08 | -0.07 | -0.09 |
| Book Value | 45.03M | 118.25M | 189.63M | 138.70M | 65.02M | 59.81M | 27.29M | 15.48M | 11.39M | 7.86M | 7.73M | 6.73M |
| Cash & ST Investments | 21.94M | 94.54M | 153.15M | 99.89M | 29.49M | 30.11M | 19.05M | 7.82M | 4.81M | 1.58M | 1.96M | 1.22M |
| ROC Equity | -1.53 | -1.27 | -0.20 | -0.27 | -0.28 | -0.18 | -0.28 | -0.25 | -0.22 | -0.35 | -0.32 | -0.31 |